International Journal of Drug Delivery Technology
Volume 14, Issue 3

Chrysin Embedded Metal Organic Framework for Anticancer Drug Delivery

VK Patil1*, JK Patel2, AK Patel3

1Department of Pharmaceutics, Mumbai Education Trust Institute of Pharmacy, Nashik, Maharashtra, India

2Vice president Viesain Pharma, LLC, USA.

3Associate Formulation Scientist, Saffron Health, LLC, USA.

Received: 20th February, 2024; Revised: 27th March, 2024; Accepted: 05th August, 2024; Available Online: 25th September, 2024

ABSTRACT

Metal-organic frameworks (MOFs) have garnered significant attention in the field of cancer drug delivery owing to their porosity, high drug-loading capacity, and large surface area. In our recent research, we synthesized a redox-responsive MOF using zirconium (Zr) as the metal ion and 4,4-dithiobisbenzoic acid (DTBA) as the organic linker. The synthesis method employed was the hydrothermal method, and it was observed that the MOF synthesized at 400°C had a particle size of less than 200 nm and a zeta potential of +35 mV, indicating its suitability as a carrier for drug delivery. Chrysin, a natural anticancer drug, was used in this study. Glutathione, which is abundantly present in tumor cells, cleaves the disulfide bond in the organic ligand (DTBA), leading to faster drug release. By incorporating chrysin into the synthesized MOF, we observed faster in vitro drug release, with 88 and 89% at pH 7.4 and 5.5, respectively. The synthesis of ZrDTBA MOF opens up new opportunities for its application in drug delivery.

Keywords: Meta organic framework, Chrysin, Redox responsive, Glutathione, Cancer. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.3.11

How to cite this article: Patil VK, Patel JK, Patel AK. Chrysin Embedded Metal Organic Framework for Anticancer Drug Delivery. International Journal of Drug Delivery Technology. 2024;14(3):1328-1333.

REFERENCES

  1. Ackermann S, Mrowka R. Cancer–An ongoing fight searching for reasons and Acta Physiologica. 2019 May 1;226(1). DOI : 10.1111/apha.13275
  2. Bashir Chemotherapy for Cancer: What It Is and How It Works.2023 March 26.DOI: 10.31219/osf.io/7wk98
  3. Mukherji Role of Chemotherapy in Management of Cancers. Basics of Planning and Management of Patients during Radiation Therapy: A Guide for Students and Practitioners. 2018:29-33. DOI: 10.1007/978-981-10-6659-7_4
  4. Arafat Y, Loft M, Cao K, Reid F, Kosmider S, Lee M, Gibbs P, Faragher IG, Yeung JM. Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments. ANZ Journal of Surgery. 2022 Nov;92(11):2784. DOI:10.1111/ans.18046
  5. Shah MR, Imran M, Ullah S. Nanocarriers for cancer diagnosis and targeted Elsevier; 2019 Jul 13.DOI: 10.1016/ B978-0-12-816773-1.00001-8
  6. Liu J, Li S, Wang J, Li N, Zhou J, Chen H. Application of nano drug delivery system (NDDS) in cancer therapy: A Recent patents on anticancer drug discovery. 2023 May 1;18(2):125-32. DOI: 10.2174/1574892817666220713150521
  7. Sharma S. Novel Drug Delivery Approach in Cancer Therapy. Research & Reviews: Journal of Pharmacy and Pharmaceutical Sciences, 2016 June 30.
  8. Zhou P. The design of metal-organic frameworks (MOFs) in hydrogen storage applications. Applied and Computational Eng i neer i 2023 ,7,196 -201. DOI: 10 . 54254/2755 - 2721/7/20230443
  9. Shi W, Li W, Nguyen W, Chen W, Wang J, Chen Advances of metal organic frameworks in analytical applications. Materials Today Advances. 2022 Aug 1; 15:100273. DOI: 10.1016/j. mtadv.2022.100273
  10. Wen X, Lin L, Li S. Current trends in MOF (Metal-Organic framework) and metal X-ides. International Journal of Molecular 2023 Jul 7;24(13):11188. DOI: 10.3390/ijms241311188
  11. Raptopoulou Metal-organic frameworks: Synthetic methods and potential applications. Materials. 2021 Jan 9;14(2):310. DOI: 10.3390/MA14020310
  12. Hyjek K, Jodłowski P. Metal-organic frameworks for efficient drug adsorption and Scientiae Radices. 2023; 2:115-89. DOI: 10.58332/scirad2023v2i2a03
  13. Rabiee N. Sustainable metal-organic frameworks (MOFs) for drug delivery systems. Materials Today Communications. 2023 Jun 1; 35:106244. DOI: 10.1016/j.mtcomm.2023.106244
  14. Ernst M, Gryn’ova Engineering Host–Guest Interactions in Organic Framework Materials for Drug Delivery. Helvetica Chimica Acta. 2023 Jun;106(6): e202300013.DOI: 10.1002/ hlca.202300013
  15. Abazari R, Mahjoub AR, Slawin AM, Carpenter-Warren CL. Morphology-and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anticancer drugs and their applicability for adsorption of amoxicillin from aqueous Ultrasonics Sonochemistry. 2018 Apr 1; 42:594-608. DOI: 10.1016/j. ultsonch.2017.12.032
  16. Gao X, Cui R, Ji G, Liu Z. Size and surface controllable metal– organic frameworks (MOFs) for fluorescence imaging and cancer Nanoscale. 2018;10(13): 6205-11.DOI: 10.1039/ C7NR08892B
  17. Xu X. The applications and synthesis of metal-organic frameworks in nano-drug delivery. Highlights in Science, Engineering and 2022 Dec 4;21: 42-9.DOI: 10.54097/ hset.v21i.3136
  18. Mishra S, Ulucan-Karnak F, Kuru Cİ. Recent advancementsin metal-organic frameworks for drug delivery. InAdvanced functional metal-organic frameworks 2023 May 1 (pp. 157-167). CRC Press.
  19. Shu G, Zhao H, Zhang Persistent luminescent metal–organic framework nanocomposite enables autofluorescence-free dual modal imaging-guided drug delivery. Biomaterials Science. 2023;11(5): 1797-809.DOI :10.1039/D2BM01920E
  20. Kundu S, Swaroop AK, Selvaraj J. Metal-organic framework in pharmaceutical drug delivery. Current Topics in Medicinal 2023 May 1;23(13): 1155-70.DOI: 10.2174/1568026623666230202122519
  21. Cui R, Zhao P, Yan Y, Bao G, Damirin A, Liu Z. Outstanding drug-loading/release capacity of hollow Fe-metal–organic framework-based microcapsules: a potential multifunctional drug-delivery Inorganic Chemistry. 2021 Jan 12;60(3): 1664-71.DOI: 10.1021/acs.inorgchem.0c03156
  22. Pederneira N, Newport K, Lawson S, Rownaghi AA, Rezaei F. Drug delivery on Mg-MOF-74: The effect of drug solubility on pharmacokinetics. ACS applied bio materials. 2023 Jun 8;6(6): 2477-86.DOI: 10.1021/acsabm.3c00275
  23. Angkawijaya AE, Bundjaja V, Santoso SP, Go AW, Lin SP, Cheng KC, Soetaredjo FE, Ismadji Biocompatible and biodegradable copper-protocatechuic metal-organic frameworks as rifampicin carrier. Biomaterials Advances. 2023 Mar 1; 146:213269. DOI: 10.1016/j.bioadv.2022.213269
  24. Tarasi S, Ramazani A, Morsali A, Hu ML, Ghafghazi S, Tarasi R, Ahmadi Drug Delivery Using Hydrophilic Metal–Organic Frameworks (MOFs): Effect of Structure Properties of MOFs on Biological Behavior of Carriers. Inorganic Chemistry. 2022 Aug 10;61(33): 13125-32.DOI: 10.1021/acs.inorgchem.2c01820
  25. Barathan M, Vellasamy KM, Mariappan V, Venkatraman G, Vadivelu Naturally Occurring Phytochemicals to Target BreastCancer Cell Signaling. Applied Biochemistry and Biotechnology. 2023 Sep 29: 1-7.DOI: 10.1007/s12010-023-04734-0.
  26. Xia Y, Chen R, Lu G, Li C, Lian S, Kang TW, Jung Natural phytochemicals in bladder cancer prevention and therapy. Frontiers in Oncology. 2021 Apr 30;11: 652033.DOI: 10.3389/ fonc.2021.652033
  27. Kumar G, Virmani T, Sharma A, Pathak K. Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers. Pharmaceutics. 2023 Mar 9;15(3): 889.DOI: 3390/pharmaceutics15030889
  28. Salari N, Faraji F, Jafarpour S, Faraji F, Rasoulpoor S, Dokaneheifard S, Mohammadi M. Anticancer activity of chrysin in cancer therapy: a systematic review. Indian Journal of Surgical Oncology. 2022 Dec;13(4): 681-90.DOI :10.1007/ s13193-022-01550-6
  29. Xuan HZ, Zhang JH, Wang YH, Fu CL, Zhang W. Anti-tumor activity evaluation of novel chrysin–organotin compound in MCF-7 cells. Bioorganic & medicinal chemistry letters. 2016 Jan 15;26(2): 570-4.DOI: 10.1016/j.bmcl.2015.11.072
  30. Cetinkaya S. Chrysin Mediates the Induction of Apoptosis in Breast Cancer Cells via the Inhibition of the WNT/β-Catenin Signaling Pathway.DOI: 10.20944/preprints202310. 0736.v1
  31. Sassi A, Maatouk M, Bzéouich IM, Hatira SA, Jemni-Yacoub S, Ghedira K, Chekir-Ghedira Chrysin, a natural and biologically active flavonoid suppresses tumor growth of mouse B16F10 melanoma cells: in vitro and in vivo study. Chemico-Biological Interactions. 2018 Mar 1;283: 10-9.DOI: 10.1016/j.cbi.2017.11.022
  32. Halevas E, Mavroidi B, Antonoglou O, Hatzidimitriou A, Sagnou M, Pantazaki AA, Litsardakis G, Pelecanou M. Structurally characterized gallium–chrysin complexes with anticancer potential. Dalton Transactions. 2020;49(8): 2734-46.DOI: 1039/C9DT04540F.